Cargando…

Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?

PURPOSE: Diagnosing germ cell neoplasia in situ (GCNis) can detect germ cell tumours (GCTs) at the pre-invasive stage. To date, testicular biopsy with the potential of surgical complications is the only way of safely diagnosing GCNis. Recently, microRNAs (miRs) 371-3, and miR 367 were shown to be va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radtke, A., Cremers, J.-F., Kliesch, S., Riek, S., Junker, K., Mohamed, S. A., Anheuser, P., Belge, G., Dieckmann, K.-P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Article – Clinical Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640733/ https://www.ncbi.nlm.nih.gov/pubmed/28819887 http://dx.doi.org/10.1007/s00432-017-2490-7

Ejemplares similares

Graded expression of microRNA-371a-3p in tumor tissues, contralateral testes, and in serum of patients with testicular germ cell tumor
por: Belge, Gazanfer, et al.
Publicado: (2020)

Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin
por: Belge, Gazanfer, et al.
Publicado: (2020)

MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours
por: Dieckmann, K-P, et al.
Publicado: (2012)

MicroRNA-371a-3p—The Novel Serum Biomarker in Testicular Germ Cell Tumors
por: Nestler, Tim, et al.
Publicado: (2023)

Serum Levels of MicroRNA-371a-3p (M371) Can Predict Absence or Presence of Vital Disease in Residual Masses After Chemotherapy of Metastatic Seminoma
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2022)

Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2021)

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2019)

Testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age—a statistical analysis
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2023)

The Two Stem Cell MicroRNA Gene Clusters C19MC and miR-371-3 Are Activated by Specific Chromosomal Rearrangements in a Subgroup of Thyroid Adenomas
por: Rippe, Volkhard, et al.
Publicado: (2010)

microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients
por: van Agthoven, Ton, et al.
Publicado: (2017)

Is there still a place for retroperitoneal lymph node dissection in clinical stage 1 nonseminomatous testicular germ-cell tumours? A retrospective clinical study
por: Dieckmann, K.-P., et al.
Publicado: (2018)

On the origin of germ cell neoplasia in situ: Dedifferentiation of human adult Sertoli cells in cross talk with seminoma cells in vitro
por: Fink, Cornelia, et al.
Publicado: (2021)

Fibrillin-1 (FBN-1) a new marker of germ cell neoplasia in situ
por: Cierna, Z., et al.
Publicado: (2016)

MicroRNA-371-3 cluster as biomarkers for the diagnosis and prognosis of cancers
por: Pan, Bei, et al.
Publicado: (2019)

MicroRNA-371-5p targets SOX2 in gastric cancer
por: Li, Yu-Ji, et al.
Publicado: (2016)

Assessment of piRNA biogenesis and function in testicular germ cell tumors and their precursor germ cell neoplasia in situ
por: Gainetdinov, Ildar V., et al.
Publicado: (2018)

Activation of the two microRNA clusters C19MC and miR-371-3 does not play prominent role in thyroid cancer
por: Rippe, Volkhard, et al.
Publicado: (2012)

The combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens
por: Kremer, Lara, et al.
Publicado: (2021)

Clinical utility of plasma miR‐371a‐3p in germ cell tumors
por: Mego, Michal, et al.
Publicado: (2018)

Retraction: MicroRNA-371-5p targets SOX2 in gastric cancer
por: Li, Yu-Ji, et al.
Publicado: (2018)

MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors
por: Schönberger, Stefan, et al.
Publicado: (2022)

Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer
por: Regouc, Manuel, et al.
Publicado: (2020)

Radiotherapy with 16 Gy may fail to eradicate testicular intraepithelial neoplasia: preliminary communication of a dose-reduction trial of the German Testicular Cancer Study Group
por: Classen, J, et al.
Publicado: (2003)

MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients
por: Terbuch, Angelika, et al.
Publicado: (2018)

Refining the serum miR-371a-3p test for viable germ cell tumor detection
por: Lafin, John T., et al.
Publicado: (2023)

Pathobiology of Human Germ Cell Neoplasia
por: Ledermann, J.A.
Publicado: (1992)

Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2019)

Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs)
por: Pierconti, Francesco, et al.
Publicado: (2019)

Optimized detection of germ cell neoplasia in situ in contralateral biopsy reduces the risk of second testis cancer
por: Rajpert‐De Meyts, Ewa, et al.
Publicado: (2022)

Fungal Planet description sheets: 371–399
por: Crous, P.W., et al.
Publicado: (2015)

Comparative Analyses of Liquid-Biopsy MicroRNA371a-3p Isolation Protocols for Serum and Plasma
por: Timmerman, Dennis M., et al.
Publicado: (2021)

Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruption
por: Bailey, Shivani, et al.
Publicado: (2023)

MON-371 The Case of Dueling Femurs
por: Patel, Richa, et al.
Publicado: (2020)

Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors
por: Murray, Matthew J, et al.
Publicado: (2020)

Cellular origin of microRNA‐371a‐3p in healthy males based on systematic urogenital tract tissue evaluation
por: Boellaard, W. P. A., et al.
Publicado: (2019)

Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data
por: Lobo, João, et al.
Publicado: (2019)

Correction: Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruption
por: Bailey, Shivani, et al.
Publicado: (2023)

CPPED1-targeting microRNA-371a-5p expression in human placenta associates with spontaneous delivery
por: Daddali, Ravindra, et al.
Publicado: (2020)

The Role of MicroRNAs in Myeloproliferative Neoplasia
por: Alizadeh, Shaban, et al.
Publicado: (2016)

CRIPTO and miR-371a-3p Are Serum Biomarkers of Testicular Germ Cell Tumors and Are Detected in Seminal Plasma from Azoospermic Males
por: Spiller, Cassy M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dk450clk8gn9j29far8bbc5iar